Literature DB >> 10812069

Hormonal regulation of organic cation transporter OCT2 expression in rat kidney.

Y Urakami1, M Okuda, H Saito, K Inui.   

Abstract

Rat (r) OCT2 was identified as the second member of the organic cation transporter (OCT) family, and is predominantly expressed in the kidney. We reported previously that rOCT2 was responsible for the gender differences in renal basolateral membrane organic cation transport activity. As renal rOCT2 expression in males is much higher than that in females, we hypothesized that rOCT2 expression may be under the control of sex hormones. Treatment of male and female rats with testosterone significantly increased the expression levels of rOCT2 mRNA and protein in the kidney, whereas estradiol treatment moderately decreased the expression levels of rOCT2. There was no regulation of renal rOCT1 mRNA expression by testosterone or estradiol. Treatment of male and female rats with testosterone significantly stimulated the tetraethylammonium (TEA) accumulation by renal slices, whereas estradiol treatment caused a decrease in the TEA accumulation by slices from male but not female rats. The present findings suggested that testosterone up-regulates renal rOCT2 expression and estradiol moderately down-regulates rOCT2.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10812069     DOI: 10.1016/s0014-5793(00)01525-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  34 in total

1.  Gender-Related Differences in the Expression of Organic Cation Transporter 2 and its Role in Urinary Excretion of Metformin in Rats.

Authors:  Yan-Rong Ma; Hong-Yan Qin; Yong-Wen Jin; Jing Huang; Miao Han; Xing-Dong Wang; Guo-Qiang Zhang; Yan Zhou; Zhi Rao; Xin-An Wu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-10       Impact factor: 2.441

Review 2.  Regulation of organic cation transport.

Authors:  Giuliano Ciarimboli; Eberhard Schlatter
Journal:  Pflugers Arch       Date:  2004-11-16       Impact factor: 3.657

3.  Metformin Accumulation Correlates with Organic Cation Transporter 2 Protein Expression and Predicts Mammary Tumor Regression In Vivo.

Authors:  L Allyson Checkley; Michael C Rudolph; Elizabeth A Wellberg; Erin D Giles; Reema S Wahdan-Alaswad; Julie A Houck; Susan M Edgerton; Ann D Thor; Pepper Schedin; Steven M Anderson; Paul S MacLean
Journal:  Cancer Prev Res (Phila)       Date:  2017-02-02

4.  Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules.

Authors:  Y Urakami; M Okuda; S Masuda; M Akazawa; H Saito; K Inui
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

5.  Organic cation uptake is enhanced in bcrp1-transfected MDCKII cells.

Authors:  Guoyu Pan; Tate N Winter; John C Roberts; Carolyn A Fairbanks; William F Elmquist
Journal:  Mol Pharm       Date:  2010-02-01       Impact factor: 4.939

6.  Organic Cation Transporter 2 Overexpression May Confer an Increased Risk of Gentamicin-Induced Nephrotoxicity.

Authors:  Zhibo Gai; Michele Visentin; Christian Hiller; Evelin Krajnc; Tongzhou Li; Junhui Zhen; Gerd A Kullak-Ublick
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

7.  Functional implications of the sex differences in transporter abundance along the rat nephron: modeling and analysis.

Authors:  Rui Hu; Alicia A McDonough; Anita T Layton
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-30

8.  Gender differences in renal tubular taurocholate transport.

Authors:  Jan Henrik Schlattjan; Frank Biggemann; Joachim Greven
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-07-23       Impact factor: 3.000

Review 9.  How important are gender differences in pharmacokinetics?

Authors:  Bernd Meibohm; Ingrid Beierle; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

10.  Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity.

Authors:  Yoshitaka Saito; Masaki Kobayashi; Takehiro Yamada; Kumiko Kasashi; Rio Honma; Satoshi Takeuchi; Yasushi Shimizu; Ichiro Kinoshita; Hirotoshi Dosaka-Akita; Ken Iseki
Journal:  Support Care Cancer       Date:  2016-10-03       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.